Keratinopathic ichthyosis
diseaseOn this page
Also known as KPI
Summary
Keratinopathic ichthyosis (MONDO:0017266) is a disease (an umbrella term covering 5 Mondo subtypes). A subtype of inherited ichthyosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: 1-9 / 1 000 000 (France) [Orphanet-validated]
- Umbrella term: 5 Mondo subtypes
Clinical features
Epidemiology
Prevalence records
1 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Point prevalence | 1-9 / 1 000 000 | 0.11 | France | Validated |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | keratinopathic ichthyosis |
| Mondo ID | MONDO:0017266 |
| Orphanet | 281103 |
| ICD-11 | 992865924 |
| SNOMED CT | 724837004 |
| UMLS | C4511307 |
| MedGen | 1393111 |
| GARD | 0021107 |
| Is cancer (heuristic) | no |
Also known as: KPI
Disease family
This is a subtype of inherited ichthyosis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › integumentary system disorder › skin disorder › epidermal disease › ichthyosis › inherited ichthyosis › keratinopathic ichthyosis
Related subtypes (12): congenital cataract-ichthyosis syndrome, Netherton syndrome, ichthyosis-oral and digital anomalies syndrome, recessive X-linked ichthyosis, neonatal ichthyosis-sclerosing cholangitis syndrome, autosomal recessive congenital ichthyosis, peeling skin syndrome, ichthyosis vulgaris, ichthyosis linearis circumflexa, IFAP syndrome, ichthyosis hystrix, ichthyosis with erythrokeratoderma
Subtypes (5): epidermolytic ichthyosis, ichthyosis hystrix of Curth-Macklin, superficial epidermolytic ichthyosis, congenital reticular ichthyosiform erythroderma, epidermolytic nevus
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.